1995
DOI: 10.1021/jm00011a019
|View full text |Cite
|
Sign up to set email alerts
|

.sigma. Ligands with Subnanomolar Affinity and Preference for the .sigma.2 Binding Site. 1. 3-(.omega.-Aminoalkyl)-1H-indoles

Abstract: A series of 4-(1H-indol-3-yl)-1-butyl-substituted 4-phenylpiperidines, 4-phenyl-1,2,3,6-tetrahydropyridines, and 4-phenylpiperazines was synthesized. The phenyl group was optionally substituted with 4-fluoro or 2-methoxy substituents. High affinity for both sigma 1 and sigma 2 binding sites was achieved with these compounds. Additionally, these compounds had relatively high affinity for serotonin 5-HT1A and 5-HT2A, dopamine D2, and adrenergic alpha 1 receptors. Introduction of a 4-fluorophenyl substituent at t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
96
0
1

Year Published

1998
1998
2012
2012

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 109 publications
(100 citation statements)
references
References 13 publications
3
96
0
1
Order By: Relevance
“…22 Siramesine and 3 H-siramesine (reviewed in ref. 23) were kindly provided by Christian Thomsen (Lundbeck A/S, Valby, Denmark). Rimcazole, haloperidol, (+)-pentazocine, α-tocopherol, 3-MA, rapamycin, NH 4 Cl, bafilomycin A and concanamycin A were from SIGMA-Aldrich (St Louis, MO, USA).…”
Section: Methodsmentioning
confidence: 99%
“…22 Siramesine and 3 H-siramesine (reviewed in ref. 23) were kindly provided by Christian Thomsen (Lundbeck A/S, Valby, Denmark). Rimcazole, haloperidol, (+)-pentazocine, α-tocopherol, 3-MA, rapamycin, NH 4 Cl, bafilomycin A and concanamycin A were from SIGMA-Aldrich (St Louis, MO, USA).…”
Section: Methodsmentioning
confidence: 99%
“…23). The recombinant human TNF was kindly provided by A. Cerami (Kenneth Warren Laboratories, Tarrytown) and the cathepsin B inhibitor R-2525 by B. Rydzewski (Celera Applied Biosystems, Foster City, CA).…”
Section: Methodsmentioning
confidence: 99%
“…23,24), was originally developed for the treatment of anxiety and depression (25). Although the clinical trials failed to show the requested efficacy in the treatment of psychiatric disorders, they presented siramesine as a nontoxic and well-tolerated compound in humans.…”
Section: Introductionmentioning
confidence: 99%
“…Although reports of σ 2 ligands abound in the literature (Bertha et al, 1995;Bowen et al, 1995a,b;Kassiou et al, 2005;Mach et al, 1995;Maeda et al, 2002;Maier and Wunsch, 2002;Perregaard et al, 1995;Vangveravong et al, 2006), the primary criterion for these claims appears to be reasonable affinity for this receptor subtype relative to σ 1 , with little consideration for selectivity as compared to non-σ binding sites. In addition, the few σ 2 compounds that have been tested in functional studies appear to act as agonists (Bowen et al, 1995a,b;Crawford et al, 2002;Vilner and Bowen, 2000).…”
Section: Introductionmentioning
confidence: 99%